A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.


Volume 6,
Issue 11

Remdesivir Approved as First COVID-19 Treatment

In a move heralding the first COVID-19 treatment to receive approval from the U.S. Food and Drug Administration (FDA), the antiviral drug remdesivir has been approved for treating patients hospitalized with COVID-19.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy